Professor Gary Anderson is a pharmacologist and immunologist in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. He serves as Professor in the Department of Biochemistry and Pharmacology, School of Biomedical Sciences, founding Director of the Lung Health Research Centre, and Head of the Lung Disease Research Laboratory. His research centers on the molecular basis of chronic degenerative lung diseases, including severe refractory asthma, chronic obstructive pulmonary disease (COPD), asthma-COPD overlap, the COPD-lung cancer interface, and fibrotic lung diseases. Key areas of investigation include the role of Src family kinases and their regulators, immune system failure in COPD, pathogenic biomarkers such as serum amyloid A (SAA) linked to chronic inflammation, cancer, and healing failure, and the gp130 system in IL-6 family cytokine signaling that contributes to fibrotic and destructive lung disease.

The laboratory led by Professor Anderson collaborates with specialists in molecular and mouse model systems and clinicians at the Royal Melbourne Hospital to translate research findings into new therapies, with several experimental medicines now in advanced clinical trials. He has authored more than 240 highly cited manuscripts on lung disease research, advancing translational efforts at the interface of genetic disease models and clinical studies. Professor Anderson recently received an NHMRC Development Grant to investigate strategies for reducing mucus hypersecretion in chronic lung diseases. As a Fellow of the Australian Academy of Health and Medical Sciences, his contributions have significantly influenced the field of respiratory medicine through mechanisms and treatments for asthma and other lung conditions.

Professional Email: gpa@unimelb.edu.au